SCHEMBL31396222

SCHEMBL31396222

CS(=O)(=O)c1ccc(C(=O)CSc2nnnn2-c2ccc(C(=O)O)c(C3CC3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 4/20 0.47
▸ ALPG P10696 4/20 0.47
▸ MAPT P10636 6/20 0.47
▸ TSHR P16473 3/20 0.46
▸ LMNA P02545 5/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ POLB P06746 3/20 0.45
▸ GAA P10253 3/20 0.45
▸ RECQL P46063 3/20 0.45
▸ JAK2 O60674 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ USP2 O75604 2/20 0.45
▸ PTP4A3 O75365 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ PLAA Q9Y263 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952011 0.90 LMNA (0.47) ALPLALPGMAPTTSHRLMNA
SCHEMBL31396338 0.85 ALPL (0.43) ALPLALPGMAPTTSHRLMNA
SCHEMBL21952009 0.83 MAPT (0.60) ALPLALPGMAPTTSHRLMNA
SCHEMBL21952042 0.76 MAPT (0.59) ALPLALPGMAPTTSHRLMNA
SCHEMBL24019587 0.75 ALOX5 (0.39) MAPTTSHRLMNASMN1; SMN2KMT2A
SCHEMBL21952035 0.74 MAPT (0.59) ALPLALPGMAPTTSHRLMNA
SCHEMBL29798375 0.74 ALDH1A1 (0.44) ALPLALPGMAPTTSHRLMNA
SCHEMBL21952069 0.74 ALDH1A1 (0.44) ALPLALPGMAPTTSHRLMNA
SCHEMBL21951986 0.73 MAPT (0.71) ALPLALPGMAPTTSHRLMNA
SCHEMBL21952052 0.72 KMT2A (0.63) ALPLALPGMAPTTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-B Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2025-03-04 — — CN disclosed
Send feedback